STREAM #4
CELL THERAPY

The Cell Therapy stream explores the critical challenges facing the manufacture, analysis and quality of cell-based therapies. Topics include product and process characterization, CMC strategies, autologous and allogeneic manufacturing strategies, automation, scale-up and supply of CAR Ts and next-generation cell therapies such as NK cells, TILs, iPSCs and TCR-based therapies. 

Conferences Include:


Keynote and Featured Presentations


Potency Assay Development for Cell-Based Therapies
Therese Choquette, PhD, Director, Analytics, Tigen


 

Method Development Strategy for Release Methods
Akshata Ijantkar, Senior Scientist, Analytical Development, Bristol Myers Squibb Co.


 

CMC Challenges with CAR T Manufacturing: Reimagining Process and Product Control Strategy
Sunitha Lakshminarayanan, Head & Executive Director, Cell Therapy Global Process Engineering, Bristol Myers Squibb Co.


 

AI, Digitalization in Cell Therapy Manufacturing
Krishnendu Roy, PhD, Robert A. Milton Chair & Director, Center for Cell Manufacturing & Center for Immuno-Engineering, Georgia Institute of Technology


 

Current Challenges in Cell Therapy CMC
Current Challenges in Cell Therapy CMC Bruce S. Thompson, PhD, Vice President and Technical Lead, Cell Therapy, National Resilience, Inc.


 


Register